Latest News about BIO
Recent news which mentions BIO
10 Biggest Price Target Changes For Monday
September 24, 2018
From Benzinga
uBiome is jumping into therapeutics with a healthy $83 million in Series C financing
September 21, 2018
From TechCrunch
Benzinga's Top Upgrades, Downgrades For September 20, 2018
September 20, 2018
From Benzinga
Apple’s Watch isn’t the first with an EKG reader but it will matter to more consumers
September 12, 2018
From TechCrunch
Google Street View cars will be roaming around the planet to check our air quality with these sensors
September 12, 2018
From TechCrunch
Interview with Priscilla Chan: Her super-donor origin story
September 09, 2018
From TechCrunch
CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable
September 06, 2018
From TechCrunch
Benzinga's Top Upgrades, Downgrades For September 5, 2018
September 05, 2018
From Benzinga
The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration
August 30, 2018
From Benzinga
George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla
August 29, 2018
From TechCrunch
From TechCrunch
RDMD attacks rare diseases with data mined from health records
August 20, 2018
From TechCrunch
The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings
August 09, 2018
From Benzinga
10 Biggest Price Target Changes For Wednesday
August 08, 2018
From Benzinga
The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict
August 08, 2018
From Benzinga
The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel
August 07, 2018
From Benzinga
Earnings Scheduled For August 7, 2018
August 06, 2018
From Benzinga
Clear for beer: Biometrics provider now enables alcohol purchases at Seahawks and Mariners games
August 06, 2018
From TechCrunch
The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter
August 02, 2018
From Benzinga
Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter
July 27, 2018
From Benzinga
Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold
July 26, 2018
From Benzinga
Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile
July 25, 2018
From Benzinga
Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering
July 24, 2018
From Benzinga
Benzinga's Daily Biotech Pulse: PTC To Buy Agilis, Zynerba To Offer Shares, Intuitive Surgical's Strong Q2
July 20, 2018
From Benzinga
Tickers
BIO
From TechCrunch
Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares
July 11, 2018
From Benzinga
From TechCrunch
Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111
June 13, 2018
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.